MoSAIC: Multi-Resolution Spatial Regression Analysis of Cellular Colocalizations in Cancer Imaging

Jessica Aldous, Michele Peruzzi, Maria Masotti, Aaron Udager, Allison May, Evan Keller, Veerabhadran Baladandayuthapani · 2026

Read MoSAIC: Multi-Resolution Spatial Regression Analysis of Cellular Colocalizations in Cancer Imaging by Jessica Aldous, Michele Peruzzi, Maria Masotti, Aaron Udager, Allison May, Evan Keller, Veerabhadran Baladandayuthapani (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2605-30287.txt.

Introduction

Jessica Aldous and six co-authors propose MoSAIC, a Bayesian model for multi-scale analysis of cell colocalizations in cancer imaging. Multiplex imaging gives resolved cell readings across views within tumors, showing microenvironment layout along tumor gradients. MoSAIC splits change into global tumor-gradient effects, patient effects, and Gaussian models for spatial links between views. Tests show improved prediction over spatial and other options. In a renal cancer cohort, MoSAIC finds more macrophage-tumor colocalization and less cytotoxic T-tumor colocalization across the gradient.

Catalog record

CREATORJessica Aldous, Michele Peruzzi, Maria Masotti, Aaron Udager, Allison May, Evan Keller, Veerabhadran Baladandayuthapani
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE65658
LICENSEhttp://creativecommons.org/licenses/by/4.0/
RIGHTSCC BY
SOURCEarXiv

Source: https://arxiv.org/abs/2605.30287

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

MoSAIC: Multi-Resolution Spatial Regression Analysis of Cellular Colocalizations in Cancer Imaging Jessica Aldous, Michele Peruzzi, Maria Masotti, Aaron Udager, Allison May, Evan Keller, Veerabhadran Baladandayuthapani Abstract Hierarchical multiplex imaging approaches generate spatially resolved single-cell measurements across multiple, spatially organized fields of view (FOVs) within patient tumor specimens, thereby enabling systematic investigation of how the organization of the tumor microenvironment varies along biologically meaningful intratumoral gradients. Existing approaches fail to jointly address this multi-resolution data structure needed to recover true biological signals. We propose MoSAIC : multi-resolution spatial regression analysis of cell colocalizations , a hierarchical Bayesian spatial regression model designed for multi-resolution spatial data. MoSAIC decomposes the joint variation into three model components: (i) global tumor-gradient effects, (ii) patient-specific effects to capture inter-patient variability, and (iii) Gaussian process models to account for spatial dependence between FOVs within each patient tumor tissue. Simulations demonstrate MoSAIC has improved prediction and model fit compared to existing spatial and non-spatial model alternatives. Our method is motivated by and applied to a renal cell carcinoma multiplex imaging cohort to investigate immune–tumor colocalization patterns across the epithelial-to-mesenchymal transition (EMT) gradient. MoSAIC identifies increased macrophage–tumor colocalization and decreased cytotoxic T–tumor colocalization progressing across the increasing EMT gradient, consistent with EMT-associated immune suppression and spatially varying immune engagement. Overall, MoSAIC provides an interpretable, multi-resolution framework for quantifying spatial tumor-gradient effects in cancer imaging studies. Software is available on Github at jcaldous/MoSAIC . Keywords: Gaussian Processes, Hierarchical Bayes, Multiplex Imaging, Renal Cell Carcinoma, Spatial Regression 1 Introduction Influence of tumor microenvironment in cancer. As cancer develops, tumor cells alter their environment to support survival and progression ( 27 ). This interplay between tumor cells, immune cells and the surrounding stroma forms a complex tumor ecosystem, termed the tumor microenvironment (TME; 9 ). Evidence suggests spatial positions of immune cells within the TME can influence drug resistance ( 55 ) and either promote or suppress tumorigenesis ( 1 ). For example, a high infiltration of M2 macrophages, white blood cells involved in wound healing, can promote tumor growth and is associated with poorer patient prognosis ( 53 ). In contrast, cytotoxic T cells target tumor cells by identifying abnormal antigens and an abundance of this immune cells is generally associated with better prognosis ( 1 ). Recent developments in spatial multiplex imaging technologies, such as tissue-based cyclic immunofluorescence ( 34 ) and multiplexed ion beam imaging ( 45 ), have enabled a more systematic and quantitative investigation of the TME ( 33 ). These technologies generate rich datasets with measures of phenotypic and functional protein markers at the cellular level while maintaining the spatial relationships between cells within the tumor. Sarcomatoid renal cell carcinoma. In the context of kidney cancers, particularly renal cell carcinoma (RCC), studies have delineated the critical role of the TME and its components in RCC biology and progression ( 25 ). Of particular interest is the involvement of the TME in initiating the epithelial to mesenchymal transition (EMT), a biological process that causes epithelial cells to progressively lose their typical features for a mesenchymal-like phenotype, marking significant changes in cell invasiveness ( 24 ). The EMT is associated with sarcomatoid dedifferentiation in RCC (sRCC), an aggressive form of renal cancer ( 8 ). Importantly, sRCC is not a unique histological subtype but rather a cell dedifferentiation that can occur anywhere in the tumor. Thus, one tumor contains cells at various stages along the EMT gradient. Although the EMT is a well-described oncogenic pathway, the role of the microenvironment in initiating this transition to more aggressive disease remains poorly understood in RCC. Recent studies also revealed that sRCC is increasingly sensitive to immunotherapy compared to clear cell RCC, suggesting that immune-tumor cell colocalization may differ across the EMT gradient ( 53 ). Consequently, our primary scientific question focuses on how cellular colocalizations vary across the tumor gradient both within and across patient tumors. Tumor gradients and hierarchical multiplex imaging data. Spatial multiplex imaging data offers an ideal platform for scientific investigations of the tumor gradient, as it measures both spatial biomarker expression and cellular spatial relationships. Since tumor tissues are large and heterogeneous, studies often focus on sampling smaller subsections of the tumors, called fields of view (FOVs). These spatially resolved replicates enable the study of the TME both within and across patients in a cost-effective manner, resulting in a hierarchical data structure that we call Hierarchical Multiplex Imaging (HMI). The general structure of HMI data from our sRCC data is presented in Figure 1 . Each patient (A) has a tumor tissue scan with spatially organized FOVs sampled across the two-dimensional tumor tissue space (B). Each FOVs has a corresponding spatial distribution of the cells (C), wherein each shape and color represents a unique cell type. FOVs are colored by a continuous biomarker that tracks the EMT across the tumor tissue (D). Our scientific focus is on quantifying changes in cellular organization across this EMT gradient. Figure 1 : Hierarchical multiplex imaging data structure in sRCC . Each patient (A) has a tumor tissue scan with multiple FOVs (B). Each FOV (C) is composed of 4 different cell types (macrophages: orange diamonds, helper T: green squares, cytotoxic T: navy triangles, Tumor: black circles). FOVs are colored based on a continuous biomarker (D) of the EMT gradient (purple: clear cell; yellow: sarcomatoid). Existing methods and limitations. This HMI data structure presents several unique analytical challenges. Specifically, (a) the complex spatial relationships among cells in a single FOV; (b) the non-ignorable spatial dependency between FOVs of a single tumor tissue; and (c) the high degree of both within- and between-patient variability (heterogeneity), which must all be considered to quantify true biological gradient within and across the patient tumor tissues. Existing methods for addressing some of these challenges can be broadly split into two categories: summary-based and model-based. Several summary-based methods have been proposed ( 59 ), and they typically quantify cellular colocalizations within each image (FOV) that can be utilized in downstream cross-patient analyses ( 40 ). Examples include cross functions like Ripley’s K-cross ( 47 ) and G-cross ( 4 ), density-based methods like DIMPLE ( 36 ), and others like MIAMI ( 49 ) which models the phenotypic expression directly as opposed to the discrete cell types. These summary-based models are well-suited for characterizing immune-tumor cellular colocalizations within a single sample/FOV but ignore (spatial) relationships between FOVs. As a result, they are not readily scalable or adaptable to the hierarchical dependence structures of HMI data. Existing model-based methods are limited in their ability to account for every source of variability. Standard mixed effects regression models ( 18 ) can borrow strength across patient data, but they ignore spatial dependencies among FOVs, which can lead to artificially low p-values and inflated effect sizes ( 51 , 31 ). Neighborhood-based methods such as conditional autoregressive (CAR) models ( 7 ) are poorly suited for HMI since tumor tissues are non-conformable spaces; patient tumors have different shapes, EMT gradients, and numbers of FOVs leading to very different neighborhoods ( 5 ). Gaussian Processes (GP; 46 ) offer a more flexible alternative to capture the spatial relationships between FOVs, but currently available GP models for cellular colocalization were not developed

Read the complete text